<!DOCTYPE html>
<html lang="en-GB">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Routine Coagulation Tests - A Detailed Guide</title>
    <script src="https://cdn.tailwindcss.com"></script>
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css">
    <script src="https://cdn.jsdelivr.net/npm/feather-icons/dist/feather.min.js"></script>
    <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700;800&display=swap" rel="stylesheet">
    <style>
        body { font-family: 'Inter', sans-serif; }
        .hero-bg-coag { background-image: linear-gradient(rgba(0,0,0,0.6), rgba(0,0,0,0.6)), url('lab.jpg'); background-size: cover; background-position: center; }
        .text-shadow-lg { text-shadow: 2px 2px 4px rgba(0, 0, 0, 0.5); }
        .interactive-result:hover .tooltip { opacity: 1; visibility: visible; transform: translateY(0); }
        .tooltip { transition: opacity 0.3s, transform 0.3s; z-index: 10; }
    </style>
</head>
<body class="bg-gray-100 text-gray-800 flex flex-col min-h-screen">

    <header class="bg-white shadow-md sticky top-0 z-50">
        <!-- Standard Header Content Here -->
    </header>

    <main class="container mx-auto px-4 py-8 flex-grow">
        <section class="hero-bg-coag text-white rounded-lg p-16 mb-8 text-center shadow-lg">
            <h1 class="text-4xl md:text-6xl font-bold mb-4 text-shadow-lg">Routine Coagulation Tests</h1>
            <p class="text-lg md:text-2xl max-w-3xl mx-auto text-shadow-lg">Exploring the workhorse tests of the coagulation laboratory, what they measure, and how we interpret them.</p>
        </section>

        <section class="bg-white p-8 rounded-lg shadow-md mb-8">
            <h2 class="text-3xl font-bold text-gray-900 mb-6 text-center">Inside the Coagulation Lab</h2>
            <p class="text-lg max-w-4xl mx-auto text-center mb-8">We use automated coagulation analysers (like the Sysmex CS-series) to perform our tests. These instruments use sophisticated methods to detect clot formation in patient plasma after the addition of specific activating reagents.</p>
            <div class="grid md:grid-cols-2 gap-8">
                <div class="bg-gray-50 p-6 rounded-lg">
                    <h3 class="text-xl font-semibold mb-2"><i class="fas fa-lightbulb text-yellow-500 mr-2"></i>The Optical Detection Method</h3>
                    <p>This is the primary method for most of our tests (PT, APTT, Fibrinogen). The analyser shines a light beam through the cuvette containing the patient's plasma and the test reagent. As a fibrin clot forms, the plasma becomes more cloudy or opaque. This causes the amount of light passing through the cuvette to decrease. The analyser measures this change in light transmission, and the time taken from the addition of the reagent to the formation of the clot is recorded as the clotting time in seconds.</p>
                </div>
                <div class="bg-gray-50 p-6 rounded-lg">
                    <h3 class="text-xl font-semibold mb-2"><i class="fas fa-palette text-blue-500 mr-2"></i>Immuno-turbidimetric Methods</h3>
                    <p>For D-Dimer, we use an immuno-turbidimetric assay. This uses latex particles coated with an antibody specific to the D-Dimer fragment. When D-Dimer is present in the plasma, it causes the particles to agglutinate (clump together). This clumping increases the turbidity of the sample, which is measured by a change in light transmission. The degree of change is proportional to the concentration of D-Dimer.</p>
                </div>
            </div>
        </section>

        <section class="bg-white p-8 rounded-lg shadow-md mb-8">
            <h2 class="text-3xl font-bold text-gray-900 mb-6 text-center">The Routine Test Menu</h2>
             <div class="bg-gray-800 text-white font-mono p-6 rounded-lg shadow-inner max-w-4xl mx-auto">
                <div class="border-b-2 border-gray-500 pb-2 mb-2 grid grid-cols-3 gap-x-4"><p>TEST</p><p class="text-right">RESULT</p><p class="text-right">UNITS</p></div>
                <div class="space-y-1 mt-2">
                    <div class="interactive-result relative cursor-pointer p-1 rounded hover:bg-gray-700"><div class="grid grid-cols-3 gap-x-4"><span>Prothrombin Time (PT)</span><span class="text-right">13.5</span><span class="text-right">s</span></div><div class="tooltip absolute right-full top-0 mr-4 w-72 bg-black text-white p-3 rounded-lg opacity-0 invisible transform -translate-y-2"><p class="font-sans font-bold">Prothrombin Time</p><p class="font-sans text-sm">Measures the extrinsic and common pathways. Prolonged in liver disease, vitamin K deficiency, and DIC. The basis for the INR.</p></div></div>
                    <div class="interactive-result relative cursor-pointer p-1 rounded hover:bg-gray-700"><div class="grid grid-cols-3 gap-x-4"><span>INR</span><span class="text-right">1.0</span><span class="text-right"></span></div><div class="tooltip absolute left-full top-0 ml-4 w-72 bg-black text-white p-3 rounded-lg opacity-0 invisible transform -translate-y-2"><p class="font-sans font-bold">International Normalised Ratio</p><p class="font-sans text-sm">A standardised calculation of the PT, used to monitor patients on Warfarin therapy. Therapeutic ranges are typically 2.0-3.0 or 3.0-4.0 depending on the clinical indication.</p></div></div>
                    <div class="interactive-result relative cursor-pointer p-1 rounded hover:bg-gray-700"><div class="grid grid-cols-3 gap-x-4"><span>APTT</span><span class="text-right">32</span><span class="text-right">s</span></div><div class="tooltip absolute right-full top-0 mr-4 w-72 bg-black text-white p-3 rounded-lg opacity-0 invisible transform -translate-y-2"><p class="font-sans font-bold">Activated Partial Thromboplastin Time</p><p class="font-sans text-sm">Measures the intrinsic and common pathways. Prolonged in haemophilia A and B, von Willebrand disease, and with heparin therapy.</p></div></div>
                    <div class="interactive-result relative cursor-pointer p-1 rounded hover:bg-gray-700"><div class="grid grid-cols-3 gap-x-4"><span>Fibrinogen</span><span class="text-right">3.5</span><span class="text-right">g/L</span></div><div class="tooltip absolute left-full top-0 ml-4 w-72 bg-black text-white p-3 rounded-lg opacity-0 invisible transform -translate-y-2"><p class="font-sans font-bold">Fibrinogen</p><p class="font-sans text-sm">The precursor to fibrin, the final component of a clot. It is an acute phase protein, so is raised in inflammation. Low levels are seen in DIC and severe liver disease.</p></div></div>
                    <div class="interactive-result relative cursor-pointer p-1 rounded hover:bg-gray-700"><div class="grid grid-cols-3 gap-x-4"><span>D-Dimer</span><span class="text-right">200</span><span class="text-right">ng/mL</span></div><div class="tooltip absolute right-full top-0 mr-4 w-72 bg-black text-white p-3 rounded-lg opacity-0 invisible transform -translate-y-2"><p class="font-sans font-bold">D-Dimer</p><p class="font-sans text-sm">A specific breakdown product of a fibrin clot. A high level indicates that clotting and subsequent fibrinolysis has occurred. Used to help exclude VTE (DVT/PE). A negative result has a high negative predictive value.</p></div></div>
                </div>
            </div>
        </section>

        <section class="text-center mt-12">
            <a href="coagulation_page.html" class="bg-gray-800 text-white font-bold py-3 px-8 rounded-full hover:bg-gray-700 transition duration-300">
                <i class="fas fa-arrow-left mr-2"></i>Back to Coagulation Overview
            </a>
        </section>
    </main>

    <footer class="text-white py-8 mt-auto" style="background-color: #005EB8;">
        <!-- Standard Footer Content Here -->
    </footer>
    
    <script>
        // JS for header/footer and tooltips
    </script>
</body>
</html>
